Skip to main content
Clinical Trials/CTRI/2022/01/039523
CTRI/2022/01/039523Not yet recruiting未知

Single tracer methylene blue in the evaluation of sentinel nodes in squamous cell carcinoma of the buccal mucosa: a prospective study from a tertiary cancer center.

Kidwai Memorial Institute of Oncology0 sites0 target enrollmentStarted: TBDLast updated:

Trial Snapshot

Phase
未知
Status
Not yet recruiting

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Inclusion Criteria

  • Consecutive patients with biopsy proven, upfront operable SCC of the buccal mucosa, with no clinical or radiological evidence of cervical lymphadenopathy.

Exclusion Criteria

  • Patients who were under 18 years of age, oral cavity subsites other than buccal mucosa, with prior history of head and neck surgery, recurrent oral cancer or any form of neoadjuvant therapy, patients with palpable lymphadenopathy and those who did not consent to the procedure

Investigators

Similar Trials